Antibodies News and Research

RSS

New therapeutics for cancer

A team of scientists at the University of Liverpool has secured the services of the National Biomanufacturing Centre (NBC) to develop and manufacture antibodies against a novel cancer antigen.

1 Aug 2006

Anti-obesity vaccine keeps rats trim

Researchers at the Scripps Research Institute in California in the U.S. have developed an anti-obesity vaccine that significantly slowed weight gain and reduced body fat in rats even when they over ate.

1 Aug 2006

HHS to stockpile Anthrax immune globulin

The Department of Health and Human Services (HHS) has announced it will purchase 10,000 therapeutic courses of treatment of Anthrax Immune Globulin (AIG) from Cangene Corporation of Winnipeg, Manitoba, Canada for a total of $143,833,719.

30 Jul 2006

Vaccination with irradiated Listeria induced protective T cell immunity

Vaccines made with bacteria killed by gamma irradiation, rather than by standard methods of heat or chemical inactivation, may be more effective, say researchers.

26 Jul 2006

GSK reports significant advance in H5N1 pandemic flu vaccine programme

GlaxoSmithKline (GSK) today announced headline data showing that its H5N1 pandemic flu vaccine achieved a high immune response at a low dose of antigen.

26 Jul 2006

Interaction of proteins in the intestinal system may be allergic indicators

Researchers have identified one of the proteins that may be responsible for causing food allergies, which could lead to the development of more accurate non-invasive tests to identify true food allergies.

25 Jul 2006

First study to demonstrate IVIg effective longer than a year

A purified mixture of human antibodies called intravenous immunoglobulin (IVIg) provides lasting benefits to patients with Alzheimer's disease (AD), according to researchers at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

25 Jul 2006

Antibodies show promise in treating Alzheimer's

Researchers say infusing human antibodies into people with Alzheimer's disease appears to help stop the disease from getting worse and may even help the patients improve.

19 Jul 2006

Herceptin-linked nanoparticles for targeted cancer therapy

Albumin nanoparticles have recently proven their mettle as anticancer agents with the 2005 approval of Abraxane to treat metastatic breast cancer.

17 Jul 2006

Potential permanent genetic cure for hemophilia A

A discovery by Medical College of Wisconsin and BloodCenter of Wisconsin researchers in Milwaukee may be a key to a permanent genetic cure for hemophilia A patients, including a subset who do not respond to conventional blood transfusions.

3 Jul 2006

Buckyballs deliver multiple drugs simultaneously to tumors

Combining a monoclonal antibody known to target melanoma tumors with multiple C60 buckyballs, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have developed a new way to deliver multiple drugs simultaneously to tumors.

3 Jul 2006

Genetically-engineered antivenom to improve the treatment of snake bite

Important breakthrough in using DNA sequencing rather than actual snake venom as the means to generate antivenom.

27 Jun 2006

First-in-class biologics poised to drive malignant melanoma drug market

Decision Resources, Inc., a research and advisory firm focusing on pharmaceutical and healthcare issues, finds that first-in-class targeted biologics will enter the malignant melanoma market during the next five years.

27 Jun 2006

Researchers identify gene used to recognize pathogens

Researchers at the Johns Hopkins Bloomberg School of Public Health have identified a gene in the Anopheles gambiae mosquito's DNA that is central to the insect's ability to defend against infectious pathogens, including Plasmodium, the parasite that causes malaria in humans.

27 Jun 2006